Mandatory Guidelines for Federal Workplace Drug Testing Program

Forms and Documents

Document	Type	Status	Availability

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Collection	Type	Status	Form
7531	Mandatory Guidelines for Federal Workplace Drug Testing Program		Migrated

ICR Details

OMB Control No: 0930-0158	ICR Reference No: 200304-0930-001
Status: Historical Active	Previous ICR Reference No: 200004-0930-001
Agency/Subagency: HHS/SAMHSA	Agency Tracking No:
Title: Mandatory Guidelines for Federal Workplace Drug Testing Program
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/16/2003
	Date Received in OIRA: 04/21/2003
Terms of Clearance: Approved for use through 7/2006 with the understanding that the new questions regarding specimen validity testing will be voluntary, pending public comment and consideration during the guideline revisions. Any amendments to this package resulting from revisions to the drug testing guidelines will be resubmitted for OMB review pursuant to the PRA.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2006	07/31/2006	07/31/2003
Responses	28,384,168	0	7,093,210
Time Burden (Hours)	1,788,089	0	1,790,664
Cost Burden (Dollars)	2,071,000	0	2,016,000

---

Abstract: E.O. 12564 requires the head of each Executive Agency to establish a program to test for the use of illegal drugs by federal employees in sensitive positions and requires the Secretary of HHS to promulgate scientific and technical guidelines for drug testing programs. Includes are the recordkeeping and reporting requirements in the Mandatory Guidelines, the application form and Section B, C and D of the Inspection Checklist for the National Laboratory Certification program, and the Federal Drug Testing Custody and Control Form.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Mandatory Guidelines for Federal Workplace Drug Testing Program

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	28,384,168	7,093,210	0	0	21,290,958	0
Annual Time Burden (Hours)	1,788,089	1,790,664	0	0	-2,575	0
Annual Cost Burden (Dollars)	2,071,000	2,016,000	0	0	55,000	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/21/2003

---